Demand prospects favorable; execution remains the key

164 Views21 Jun 2021 23:01
Broker
Jubilant Pharmova (JP) hosted an investor/analyst meet to discuss the business and strategic initiatives in key business segments. With the COVID disruption behind in key markets, JP expects radiop...
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 1-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Motilal Oswal
External broker reports(aggregated public sources)
Motilal Oswal Financial Services Limited
IndiaEquity Bottom-Up
Price Chart(Sign Up to Access)
analytics-chart
  • Demand prospects favorable; execution remains the key
    21 Jun 2021
x